UNITED STATES
Lexaria Bioscience strikes R&D agreement with BAT

Lexaria Bioscience Corp has announced that it has entered into a research and development agreement with British American Tobacco Limited (BAT) to investigate its technology for potential use in nicotine products, Proactive Investors reported.

"Lexaria is pleased to work with British American Tobacco on these research and development activities," Lexaria CEO Chris Bunka was quoted as saying.
Lexaria said the agreement does not contemplate the development of oral nicotine consumer products in North America, given Lexaria's existing relationship with a leading US-based tobacco company. The agreement is expected to be completed within six months, though provisions exist to extend the agreement if required, Lexaria said.
The British Columbia-based company has developed and markets DehydraTECH, which masks unwanted tastes, improves onset speed and increases the bioavailability of active pharmaceutical ingredients in a simple and cost-effective platform. Essentially, DehydraTECH allows cannabidiol (CBD) and other oils to be dehydrated into an odorless, tasteless powder and mixed with xanthan gum, cornflour, and other base ingredients that can then be added to foods, drinks and creams, the report said.
The R&D work under the agreement will be paid for by BAT, Lexaria said in a statement.

Want to read the latest TJI?

Industrie.de Infoservice
Vielen Dank für Ihre Bestellung!
Sie erhalten in Kürze eine Bestätigung per E-Mail.
Von Ihnen ausgesucht:
Weitere Informationen gewünscht?
Einfach neue Dokumente auswählen
und zuletzt Adresse eingeben.
Wie funktioniert der Industrie.de Infoservice?
Zur Hilfeseite »
Ihre Adresse:














Die Konradin Verlag Robert Kohlhammer GmbH erhebt, verarbeitet und nutzt die Daten, die der Nutzer bei der Registrierung zum Industrie.de Infoservice freiwillig zur Verfügung stellt, zum Zwecke der Erfüllung dieses Nutzungsverhältnisses. Der Nutzer erhält damit Zugang zu den Dokumenten des Industrie.de Infoservice.
AGB
datenschutz-online@konradin.de